-Thomas A Linkhart Researcher Activity Profile

Research Author Detailed Information 

Thomas A Linkhart Publication Rate By Year

Thomas A Linkhart has published 2 paper(s) in 1986, 1 paper(s) in 1988, 5 paper(s) in 2007, for a total of 8 research publications in total.

Thomas A Ta Linkhart Author Information

LAST NAME: linkhart

FIRST NAME: Thomas A

INITIALS: ta

AFFILIATION:

Papers

Thomas A Linkhart's Publication Record

1. Maternal cocaine administration causes an epigenetic modification of protein kinase Cepsilon gene expression in fetal rat heart. Year Published: 2007
Center for Perinatal Biology, Department of Pharmacology and Physiology, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
2. Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis. Year Published: 2007
Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda, California 92357, USA.
3. Tumor Necrosis Factor-{alpha} Augments Matrix Metalloproteinase-9 Production in Skeletal Muscle Cells through the Activation of Transforming Growth Factor- -activated Kinase 1 (TAK1)-dependent Signaling Pathway. Year Published: 2007
Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda, California 92357.
4. Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway. Year Published: 2007
Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda, California 92357, USA.
5. Human skeletal growth factor stimulates collagen synthesis and inhibits proliferation in a clonal osteoblast cell line (MC3T3-E1). Year Published: 1986
6. Isolation and purification of a low-molecular-weight skeletal growth factor from human bones. Year Published: 1986
7. Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Year Published: 1988
Department of Biochemistry, Loma Linda University, CA.
8. Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway. Year Published: 2007
Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda, California 92357, USA.